Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |